DocuSign

DOCU · NASDAQ

$80.28+$3.62 (+4.72%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $76.66

DOCU analyst rating

HoldConsensus of 17 analysts over the last 12 months. 12% rate it a buy.

Strong buy0
Buy2
Hold14
Underperform1
Sell0

12-month price target · 21 analysts

Average $71.83 (−10.5% downside)

Low: $58.58
Now: $80.28
High: $90.30

Upgrades and downgrades

The latest rating actions, newest first

DOCU analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Piper Sandler	Sep 4, 2026	Maintains	Neutral	$52.00 → $75.00	72%
Citigroup	Sep 4, 2026	Maintains	Neutral	$54.00 → $72.00	56%
Morgan Stanley	Sep 4, 2026	Maintains	Equal-Weight	$69.00 → $75.00	48%
B of A Securities	Sep 4, 2026	Maintains	Underperform	$58.00 → $64.00	33%
Baird	Sep 4, 2026	Maintains	Neutral	$55.00 → $72.00	74%
Wells Fargo	Sep 4, 2026	Maintains	Equal-Weight	$55.00 → $60.00	49%
RBC Capital	Sep 4, 2026	Maintains	Sector Perform	$55.00 → $70.00	51%
UBS	Sep 4, 2026	Maintains	Neutral	$54.00 → $70.00	65%
Citizens	Sep 4, 2026	Maintains	Market Outperform	$86.00	48%
BTIG	Sep 4, 2026	Maintains	Buy	$75.00	70%

The case for and against

Updated Oct 18, 2026

Bull case

Docusign is viewed favorably because it is leveraging its dominant e-signature franchise to expand into the broader agreement layer, which can deepen customer reliance and lift spend across the platform. Its Intelligence Agreement Management product beat expectations at $529M versus $474M, is expected to exceed $650M by the end of FY27, and already represents 15.1% of total ARR, while Iris is trained on over 300 million private consented agreements. The company also delivered revenue of $876M, non-GAAP EPS of $1.16, and a 31.6% operating margin, with strong customer growth, 103% net retention, and rising free cash flow supporting the bullish outlook.

Bear case

Docusign is exposed to a core revenue stream that depends heavily on e-signature adoption, and any slowdown in that usage could pressure operating results and limit growth. The company also faces a highly competitive, evolving market, potential cyber and data-breach risks, and uncertainty around whether its total addressable market was overstated, all of which could constrain its long-term expansion. Fundamentally, the outlook is weakened by ongoing execution issues, including sales-force turnover, a 9% workforce reduction, and a credibility gap after multiple billings guidance misses and downshifts, suggesting a long and difficult turnaround.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.